Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 28, 2022
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
[ Tue, Jun 28th 2022
] - WOPRAI
Mon, June 27, 2022
[ Mon, Jun 27th 2022
] - WOPRAI
[ Mon, Jun 27th 2022
] - WOPRAI
Laura Chico Maintained (XENE) at Buy with Decreased Target to $41 on, Jun 27th, 2022
Laura Chico of Wedbush, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Decreased Target from $47 to $41 on, Jun 27th, 2022.
Laura has made no other calls on XENE in the last 4 months.
There is 1 other peer that has a rating on XENE. Out of the 1 peers that are also analyzing XENE, 0 agree with Laura's Rating of Hold.
This is the rating of the analyst that currently disagrees with Laura
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $41 on, Wednesday, May 11th, 2022
